MTIM
WST icon

Marathon Trading Investment Management’s West Pharmaceutical WST Stock Holding History

Marathon Trading Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,218
Closed -$993K – 337
2022
Q4 		$993K Buy
+4,218
New +$1,000K 0.12% 97

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marathon Trading Investment Management's WST Position: Q1 2023 in Review

Marathon Trading Investment Management sold out of West Pharmaceutical (WST) in Q1 2023, closing a stake of 4,218 shares — an estimated $993K sold.

Marathon Trading Investment Management first reported a position in WST in Q4 2022 and held it in 1 quarter. The position peaked at $993K in Q4 2022. 695 funds tracked by Wall St. Rank hold WST as of Q1 2023.

  • Marathon Trading Investment Management reported no remaining West Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • Marathon Trading Investment Management sold 4,218 West Pharmaceutical shares in Q1 2023, an estimated $993K.
  • Marathon Trading Investment Management first reported a position in West Pharmaceutical in Q4 2022 and held it in 1 quarter.
  • Marathon Trading Investment Management's West Pharmaceutical position peaked at $993K in Q4 2022.
  • 695 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2023.

Based on Marathon Trading Investment Management's 13F filing for Q1 2023, filed 12 May 2023.